ライフサイエンスコーパス: sealant

1 ng sealant alone and half bonding agent plus sealant.

2 hydrochloride) and teat sealant or just teat sealant.

3 ubsequent occlusion of the tract with fibrin sealant.

4 third the risk of failure for buccal/lingual sealants.

5 usal and 0.35 (p = 0.006) for buccal/lingual sealants.

6 s, fewer dental visits, and fewer protective sealants.

7 housing complex with PCB-contaminated joint sealants.

8 ction in the U.S. to ban the use of coal-tar sealants.

9 ge cyclic loads such as car tires or bearing sealants.

10 ge can linings, thermal receipts, and dental sealants.

11 the stability of plasma clots and of fibrin sealants.

12 accelerated lysis of in vitro clotted fibrin sealants.

13 n enhancing the structure of surgical fibrin sealants.

14 (156 patients) with no application of fibrin sealant (154 patients).

15 ween January 2006 and April 2007 (159 fibrin sealant, 160 sutures).

16 distribution of PCBs in use/storage/building sealants, ~60% of PBDE variability was related to buildi

17 the inhibitory effect of SeLECT-Defense(TM) sealant against S. mutans and S. salivarius biofilms is

18 of a split-mouth design, with half receiving sealant alone and half bonding agent plus sealant.

19 st that adding a bonding agent layer between sealant and saliva-contaminated enamel allows for adequa

20 Biological sealants and endoscopic coil implants have been used in

21 l exams to assess caries and the presence of sealants and fluorosis were performed on 2921 third-grad

22 dequate bond strength and retention of resin sealants and may improve success of all sealant applicat

23 half the usual risk of failure for occlusal sealants and one-third the risk of failure for buccal/li

24 sis: the use of increasingly advanced tissue sealants and the use of physical methods.

25 n the transportation network (e.g., pavement sealants), and improving wastewater treatment technology

26 d patching, percutaneous placement of fibrin sealant, and surgical CSF leak repair, but outcomes have

27 clinical trials on dental caries, fluorides, sealants, and "restorative" care, I identified a total o

28 e of polymeric hydrogels as wound adhesives, sealants, and hemostats, their design requirements, synt

29 promise for complex manufacturing, printing, sealants, and materials repair.

30 ionally applied topical fluorides and dental sealants, and use of fluoride toothpastes.

31 esin sealants and may improve success of all sealant applications.

32 have concluded that coal-tar-based pavement sealants are a major source of polycyclic aromatic hydro

33 Fibrin sealants are extensively used in liver surgery, for exam

34 hows that prophylactic application of fibrin sealant at the resection surface after liver resections

35 The results suggest that sealants based on ACP-filled methacrylate composites hav

36 Fibrin sealant can also be justified as an alternative to facto

37 ion (ICDAS 0-4) that are sealed with a clear sealant can be monitored with ICDAS, QLF, or DIAGNOdent,

38 ceived sealants (S) and 319 who received non-sealant care (NS).

39 ast to a control sealant, SeLECT-Defense(TM) sealant completely inhibited the growth of S. mutans.

40 through plastic consumer products and dental sealants containing BPA.

41 Fibrin sealants continue to be used and evaluated in animal mod

42 ilization can be reversed using the membrane sealant copolymer poloxamer 188.

43 Estimates for sealant costs ($27.00) and restoration costs ($73.77), a

44 If sealant costs decreased to $6.00 (reported cost for scho

45 have been resolved, chemical-based membrane sealants could represent a new therapeutic approach for

46 The prevalence of dental sealants decreased in the US adult population with incre

47 We analyzed the cost-effectiveness of 3 sealant delivery strategies: Seal all (SA), seal childre

48 ram and for future non-randomized studies of sealant effectiveness.

49 e, having preexisting sealants, or having no sealant-eligible molars or premolars.

50 , annual caries increment (0.0624 surfaces), sealant failure rate (20% in yr 1 and 3% thereafter), an

51 tment effects and potential risk factors for sealant failure were tested by means of a Cox regression

52 tle group was successful in reducing risk of sealant failure, with a hazard ratio (HR) of 0.53 (p = 0

53 Fibrin sealant for mesh fixation in Lichtenstein repair of smal

54 Fissure sealant (FS) and fluoride varnish (FV) are effective in

55 e to decline as stocks of previously applied sealant gradually become depleted.

56 groups: 24% (38/156 patients) in the fibrin sealant group and 24% (37/154 patients) in the control g

57 as detected in 14% of patients in the fibrin sealant group and in 14% of controls.

58 mL or more in 28% of patients in the fibrin sealant group and in 26% of controls (P = 0.800).

59 cation was significantly lower in the fibrin sealant group than in the sutures group (8.1% vs 14.8%;

60 Less pain was reported in the fibrin sealant group than in the sutures group at 1 and 6 month

61 This fit-to-shape sealant has potential in sealing tissues with non-flat g

62 elopment of practical and efficient surgical sealants has the propensity to improve operational outco

63 Over the past decade, dental sealants have become recognized as an important adjunct

64 Although these sealants have been developed to induce hemostasis, in pr

65 Fibrin sealants have been used to control surgical hemorrhage f

66 s emphasize the important role that diet and sealants have in preventing dental caries.

67 e paints contained 110 mug Ti/mg while three sealants (i.e., prime coat paint) contained less titaniu

68 vel metallo-bioadhesive to be used as tissue sealant in minimally invasive procedures is reported.

69 ilm effect, we soaked the SeLECT-Defense(TM) sealant in PBS for 2 mos at 37 degrees C and found that

70 HANES III-Phase 1), the prevalence of dental sealants in children, adolescents, and adults was determ

71 higher percentage of non-Hispanic whites had sealants in comparison with their non-Hispanic black and

72 th progressed to ICDAS >/= 5 associated with sealants in need of repair and none to halfway or more t

73 ecific aim of highlighting the use of fibrin sealants in planned and simulated trauma to provide back

74 meta-analysis examined the effectiveness of sealants in preventing caries progression.

75 for clinicians who may consider using fibrin sealants in specific cases.

76 ent studies have evaluated the use of fibrin sealants in vascular surgery, including aortic anastomos

77 -selenium dental sealant (SeLECT-Defense(TM) sealant) in inhibiting S. mutans and S. salivarius biofi

78 containing building materials, such as joint sealants, influence PCB levels in urban air.

79 Fibrin sealant is the most widely utilized biosurgical product.

80 ly expensive, cost can be justified when the sealant is used to produce localized hemostasis in surge

81 that the presence of coal-tar-based pavement sealants is associated with significant increases in est

82 A barrier to providing sealants is concern about inadvertently sealing over car

83 onate precipitation (MICP) over cement-based sealants is that the solutions used to promote MICP are

84 ynthesized and covalently attached to dental sealant material via standard polymer chemistry.

85 Surgical ligatures or fibrin sealants may be indicated in case of refractory CL befor

86 Test the hypothesis that fibrin sealant mesh fixation can reduce the incidence of postop

87 BLVR devices are: endobronchial valves, foam sealant, metallic coils, airway bypass stents and vapor

88 o 11 years, S and NS had equal likelihood of sealant need (OR = 1.41, 95% CI = 0.62, 3.18).

89 to 15 years, NS had a greater likelihood of sealant need (OR = 6.82, 95% CI = 1.60, 29.08).

90 ed the association between caries status and sealant need at a prior survey and subsequent sealant us

91 Prior sealant need caused variability in dentists' decisions,

92 ssociation between sealant receipt and prior sealant need varied by age.

93 NS were compared on baseline dfs, DMFS, and sealant need, controlling for the patient's age, number

94 Fibrin sealant, now commercially available in the United States

95 The prevalence of sealants on one or more permanent molars was estimated t

96 The presence of dental sealants on posterior teeth (excluding third molars) and

97 is strong evidence for the effectiveness of sealants, one major barrier in sealant utilization is th

98 ) were significant risk factors for occlusal sealants only.

99 with stapling alone, with or without tissue sealant or glue, in reducing the incidence and duration

100 with stapling alone, with or without tissue sealant or glue, in reducing the incidence and duration

101 tramammary ceftiofur hydrochloride) and teat sealant or just teat sealant.

102 subject to mesh fixation with either fibrin sealant or sutures.

103 re excluded based on age, having preexisting sealants, or having no sealant-eligible molars or premol

104 infections; interventions such as fluorides, sealants, oral hygiene, antimicrobials, and dental filli

105 monitoring of caries lesions through a clear sealant over 44 mo.

106 under the sealant, we placed SeLECT-Defense sealant over a lawn of S. mutans.

107 for the parasite cycle because the membrane sealant P1107 interferes with egress.

108 ns leading to improved adhesion and surgical sealant performance.

109 tive light-induced fluorescence (QLF) before sealant placement and 1, 12, 24, and 44 mo (except QLF)

110 ne influencing caries risk and the timing of sealant placement.

111 uish between baseline ICDAS before and after sealant placement.

112 death, and that application of the membrane sealant poloxamer 188 corrects these defects in vitro.

113 A number of sealant products have been used as an adjunct or princip

114 including conventional suture repair, tissue sealants, radiofrequency ablation, lasers, water dissect

115 The association between sealant receipt and prior sealant need varied by age.

116 s-free status was associated with subsequent sealant receipt.

117 ptor modeling results indicate that coal-tar sealants remain the largest PAH source to the lake, impl

118 The small risk of sealant repair increased significantly as baseline ICDAS

119 nt, which may aid in predicting the need for sealant repair.

120 Transformers and building sealants represent the largest legacy categories at 250

121 Sealant retention rates were excellent at 12 mo = 89%, 2

122 390 children were included: 71 who received sealants (S) and 319 who received non-sealant care (NS).

123 es the efficacy of an organo-selenium dental sealant (SeLECT-Defense(TM) sealant) in inhibiting S. mu

124 In contrast to a control sealant, SeLECT-Defense(TM) sealant completely inhibited

125 s simulation model comparing 2 primary molar sealant strategies - always seal (AS) and standard care

126 he objective was to evaluate 2 primary molar sealant strategies for publicly insured children using a

127 Scotchbond was detrimental to occlusal sealant success, with a HR of 2.96 (p = 0.0003).

128 differed between occlusal and buccal/lingual sealants, suggesting that failures on these two surfaces

129 leting detailed analyses of risk factors for sealant survival, this study shows that single-bottle bo

130 ws that single-bottle bonding agents protect sealant survival, yielding half the usual risk of failur

131 erview of the mechanisms of action of fibrin sealants, their indications, and current commercial form

132 We propose that membrane sealant therapy is a potential treatment modality for DM

133 ween relatively rigid bodies may function as sealants, thermal, electrical, or mechanical insulators,

134 ble hydrogels are approved by FDA as surgery sealants, tissue adhesives, and are now being investigat

135 compared prophylactic application of fibrin sealant to the resection surface (156 patients) with no

136 It is unclear whether application of fibrin sealant to the resection surface is effective in reducin

137 y potential scenarios exist for using fibrin sealants to control traumatic hemorrhage.

138 possibility of using polymer-based membrane sealants to prevent or reverse amyloid oligomer toxicity

139 The four study arms were: fee per sealant treatment, education in evidence-based practice,

140 analyzed to determine if the upward trend in sealant use continues.

141 ealant need at a prior survey and subsequent sealant use in a Medicaid program.

142 ic procedures are those most appropriate for sealant use in urology.

143 Substantial variability in disease and sealant utilization between counties was found.

144 ectiveness of sealants, one major barrier in sealant utilization is the concern of sealing over activ

145 estimation were used to estimate disease and sealant utilization measures for each of the counties.

146 and confocal microscopy, SeLECT-Defense(TM) sealant was found to completely inhibit the development

147 ng and lysis of human plasma clots or fibrin sealants was studied in presence or absence of human bil

148 selenium inhibits bacterial growth under the sealant, we placed SeLECT-Defense sealant over a lawn of

149 However, regardless of lesion severity, sealants were 100% effective at 12 mo and 98% effective

150 Sealants were used infrequently by most providers and fo

151 e results in lysis of plasma clots or fibrin sealants, which potentially could affect the efficacy of

152 t attenuate the lytic activity toward fibrin sealants, which suggested that tPA in a biliary environm

153 icle reviews the recent literature on fibrin sealants with the specific aim of highlighting the use o

154 ed 617 occlusal and 441 buccal/lingual molar sealants, with use of a split-mouth design, with half re

155 Dry cow therapy based on teat sealant without antibiotics can be used with no detrimen